Dimensional Fund Advisors LP Maxcyte, Inc. Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Maxcyte, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,484,357 shares of MXCT stock, worth $3.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,484,357
Previous 1,429,071
3.87%
Holding current value
$3.53 Million
Previous $5.94 Million
31.83%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$23.9 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$19.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$16.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$13.2 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$12 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $242M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...